HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Gastroenterology
RCT
Bismuth quadruple therapy shows higher H. pylori eradication in pediatric patients with clarithromycin resistance
High-Level Clarithromycin Resistance May Predict Bismuth Success in H. pylori
This observational study of 4,610 pediatric patients with H. pylori infection compared bismuth quadruple therapy to triple therapy. Bismuth …
A simple blood test level may predict which H. pylori infections respond best to bismuth therapy, turning a treatment failure sign into a gu…
medRxiv
May 2, 2026
Infectious Disease
Meta-analysis
Meta-analysis: Nitazoxanide triple therapy improves H. pylori eradication vs standard triple therapy
Nitazoxanide triple therapy significantly improves H. pylori cure rates compared to standard treatment
This systematic review and meta-analysis of 1286 participants found that nitazoxanide-based triple therapy significantly improved H.
A large review of 1286 patients found that adding nitazoxanide to standard triple therapy significantly improved H. pylori cure rates and re…
May 1, 2026
Pediatrics
Cohort
Retrospective study compares antibiotic regimens for H. pylori eradication in children
Two antibiotic regimens cleared H. pylori in most children within four weeks
This retrospective observational study evaluated two antibiotic combinations for treating Helicobacter pylori infection in children aged 4 t…
A look at two common treatments found that both regimens successfully eliminated the bacteria in most children within four weeks.
Frontiers
Apr 23, 2026
Pediatrics
Cohort
Bismuth-containing quadruple therapy associated with higher H. pylori eradication rates compared to triple therapy in children
New Mix Clears Stomach Bugs Better in Children
This retrospective cohort study of 161 pediatric patients compared 14-day bismuth-containing quadruple therapy against triple therapy for He…
A four-drug plan works better than the usual three-drug plan for clearing stomach bacteria in kids.
Frontiers
Apr 22, 2026
Infectious Disease
RCT
H. pylori eradication reduces cholesterol and LDL in patients with cardiovascular disease risk
Treating This Stomach Bug May Quietly Lower Heart Risk
A randomized controlled trial in 72 patients with H.
Treating a common stomach infection can lower cholesterol and small dense lipoprotein particles a year later, potentially reducing heart dis…
Apr 15, 2026